Dr. Reddy's sales and marketing update

Dr. Reddy's launched sirolimus tablets for the prophylaxis of organ rejection in patients older than 13 years who have had renal transplants. Pfizer Inc. (NYSE:PFE, New York, N.Y.) markets the rapamyc...